Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: A randomized, double-blinded, placebo-controlled phase 3 trial-Reference-Cited by-同舟云学术

Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: A randomized, double-blinded, placebo-controlled phase 3 trial

Published:2020-11 Issue:5 Volume:83 Page:1282-1293
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Paller Amy S.,Siegfried Elaine C.,Thaçi Diamant,Wollenberg Andreas,Cork Michael J.,Arkwright Peter D.,Gooderham Melinda,Beck Lisa A.,Boguniewicz Mark,Sher Lawrence,Weisman Jamie,O'Malley John T.,Patel Naimish,Hardin Megan,Graham Neil M.H.,Ruddy Marcella,Sun Xian,Davis John D.,Kamal Mohamed A.,Khokhar Faisal A.,Weinreich David M.,Yancopoulos George D.,Beazley Bethany,Bansal Ashish,Shumel Brad

Funder

Sanofi Genzyme

Regeneron Pharmaceuticals

Publisher

Elsevier BV

Subject

Dermatology

Reference27 articles.

1. Atopic dermatitis from adolescence to adulthood in the TOACS cohort: prevalence, persistence and comorbidities;Mortz;Allergy,2015

2. The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions;Hay;J Invest Dermatol,2014

3. A comparative study of impairment of quality of life in children with skin disease and children with other chronic childhood diseases;Beattie;Br J Dermatol,2006

4. The psychosocial burden of childhood atopic dermatitis;Chamlin;Dermatol Ther,2006

5. Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis;Eichenfield;J Am Acad Dermatol,2014

Cited by 259 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of Atopic Dermatitis in Children;Cureus;2024-09-14

2. Dupilumab treatment reduces caregiver-reported skin pain in patients with moderate-to-severe atopic dermatitis aged 6 months to 5 years;Frontiers in Pediatrics;2024-09-04

3. Atopic dermatitis and IgE-mediated food allergy;Annals of Allergy, Asthma & Immunology;2024-09

4. Current and Emerging Biologics for Atopic Dermatitis;Immunology and Allergy Clinics of North America;2024-09

5. Evaluation of dupilumab on the disease burden in children and adolescents with atopic dermatitis: A population‐based cohort study;Allergy;2024-08-21